Bioactive Compounds
-
BA1889 BMS-929075Summary: BMS-929075 is a potent orally active NS5B replicase palindromic site-modified inhibitor. - BA1888 HCV-IN-29Summary: A hepatitis C virus inhibitor.
- BA1887 KIN1400Summary: KIN1400 is a potent activator.
- BA1886 Nucleoside-Analog-1Summary: Nucleoside-Analog-1, an analog of antiviral nucleoside R1479, was used in the synthesis of HCV antiviral nucleoside analogs.
- BA1885 TrachelogeninSummary: Trachelogenin ((-)-Trachelogenin) is an entry inhibitor with no genotype specificity and low cytotoxicity.
- BA1884 LJ001Summary: LJ001 is a broad-spectrum antiviral active molecule with oral activity.
- BA1883 SetrobuvirSummary: Setrobuvir (ANA598) is an orally active non-nucleoside polymerase inhibitor.
- BA1882 NCI-B16Summary: NCI-B16 is a small molecule RNA binding agent.
- BA1881 PSI-7976Summary: PSI-7976 is an isomer of PSI-7977.
- BA1880 SamatasvirSummary: Samatasvir (IDX71) is a potent, orally active replication inhibitor.